توقعات سوق تجزئة البلازما في آسيا والمحيط الهادئ حتى عام 2028 - تأثير فيروس كورونا (COVID-19) والتحليل الإقليمي حسب المنتج (الجلوبيولين المناعي، والألبومين، ومركزات عامل التخثر، ومثبطات الأنزيم البروتيني، ومنتجات البلازما الأخرى)، والتطبيق (علم الأعصاب، وعلم المناعة، وأمراض الدم، والرعاية الحرجة، وأمراض الرئة، و التطبيقات الأخرى)، والمستخدم النهائي (المستشفيات والعيادات، ومختبرات الأبحاث السريرية، والمعاهد الأكاديمية)

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Plasma Fractionation Market – By Product

1.3.2        APAC Plasma Fractionation Market – By Application

1.3.3        APAC Plasma Fractionation Market – By End User

1.3.4        APAC Plasma Fractionation Market – By Country

2.           APAC Plasma Fractionation Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Plasma Fractionation Market – Market Landscape

4.1         Overview

4.2         APAC PEST Analysis

4.3         Experts Opinion

5.           APAC Plasma Fractionation Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Plasma Therapy is Becoming More Widely Used

5.1.2        Players' Active Involvement in Market Developments

5.2         Market Restraints

5.2.1        Options for Non-Plasma Substitutes

5.3         Market Opportunities

5.3.1        Growth Potential in Developing Countries

5.4         Future Trends

5.4.1        Novel Diseases Getting Treated with Use of Plasma Therapy

5.5         Impact Analysis

6.           Plasma Fractionation Market – APAC Analysis

6.1         APAC Plasma Fractionation Market Revenue Forecast and Analysis

7.           APAC Plasma Fractionation Market Revenue and Forecasts To 2028– by Product

7.1         Overview

7.2         APAC Plasma Fractionation Market, By Product 2021 & 2028 (%)

7.3         Immunoglobulin

7.3.1        Overview

7.3.2        Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.1          Intravenous Immunoglobulin (IVIG)

7.3.2.1.1          Overview

7.3.2.1.2          Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.2          Subcutaneous Immunoglobulin (SCIG)

7.3.2.2.1          Overview

7.3.2.2.2          Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.4         Albumin

7.4.1        Overview

7.4.2        Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.5         Coagulation Factor Concentrates

7.5.1        Overview

7.5.2        Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.6         Protease Inhibitors

7.6.1        Overview

7.6.2        Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.7         Other Plasma Products

7.7.1        Overview

7.7.2        Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

8.           APAC Plasma Fractionation Market Revenue and Forecasts To 2028 – Application

8.1         Overview

8.2         APAC Plasma Fractionation Market Share by Application 2021 & 2028 (%)

8.3         Neurology

8.3.1        Overview

8.3.2        Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Immunology

8.4.1        Overview

8.4.2        Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Hematology

8.5.1        Overview

8.5.2        Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Critical Care

8.6.1        Overview

8.6.2        Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.7         Pulmonology

8.7.1        Overview

8.7.2        Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.8         Other Applications

8.8.1        Overview

8.8.2        Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.           APAC Plasma Fractionation Market Revenue and Forecasts To 2028 – End User

9.1         Overview

9.2         APAC Plasma Fractionation Market Share by End User 2021 & 2028 (%)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Clinical Research Laboratories

9.4.1        Overview

9.4.2        Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.5         Academic Institutes

9.5.1        Overview

9.5.2        Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

10.        APAC Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis

10.1      Overview

10.1.1     APAC: Plasma Fractionation Market, by Country, 2021 & 2028 (%)

10.1.1.1       Japan: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1       Overview

10.1.1.1.2       Japan: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.3       Japan: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3.1    Japan: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.1.4       Japan: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.5       Japan: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.2       China: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.2.1       Overview

10.1.1.2.2       China: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.2.3       China: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3.1    China: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.2.4       China: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.5       China: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.3       India Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.3.1       Overview

10.1.1.3.2       India: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.3.3       India: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3.1    India: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.3.4       India: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.5       India: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.4       South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.4.1       Overview

10.1.1.4.2       South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.4.3       South Korea: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3.1    South Korea: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.4.4       South Korea: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.5       South Korea: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.5       Australia: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.5.1       Overview

10.1.1.5.2       Australia: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.5.3       Australia: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3.1    Australia: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.5.4       Australia: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.5       Australia: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.6       Rest of APAC: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of APAC: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3       Rest of APAC: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3.1    Rest of APAC: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.6.4       Rest of APAC: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.4.1    Rest of APAC: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on APAC Plasma Fractionation Market

11.1      APAC: Impact Assessment of COVID-19 Pandemic

12.        Plasma Fractionation Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Followed by Major Market Players (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic developments

12.4.1     Overview

13.        Company Profiles

13.1      Octapharma AG

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Kedrion S.p.A

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      CSL Limited

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Grifols, S.A.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Bio Products Laboratory Ltd.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Bharat Serums and Vaccines Limited (BSV)

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      SK Plasma

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      PlasmaGen BioSciences Pvt. Ltd.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Japan: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 2.             Japan: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 3.             Japan: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             Japan: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5.             China: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 6.             China: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 7.             China: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8.             China: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.             India: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 10.          India: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 11.          India: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12.          India: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          South Korea: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 14.          South Korea: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 15.          South Korea: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.          South Korea: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17.          Australia: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 18.          Australia: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 19.          Australia: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 20.          Australia: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 21.          Rest of APAC: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of APAC: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 23.          Rest of APAC: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of APAC: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 25.          Organic Developments Done By Companies

Table 26.          Inorganic developments done by Companies

Table 27.          Glossary of Terms, APAC Plasma Fractionation Market

LIST OF FIGURES

Figure 1.           APAC Plasma Fractionation Market Segmentation

Figure 2.           APAC Plasma Fractionation Market Segmentation, By Country

Figure 3.           APAC Plasma Fractionation Market Overview

Figure 4.           Immunoglobulin Segment Held the Largest Share of the Product Segment in APAC Plasma Fractionation Market

Figure 5.           Asia Pacific to Show Significant Growth During Forecast Period

Figure 6.           APAC PEST Analysis

Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to APAC Plasma Fractionation Market

Figure 8.           APAC Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028

Figure 9.           APAC Plasma Fractionation Market, by Product 2021 & 2028 (%)

Figure 10.        APAC Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        APAC Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        APAC Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        APAC Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        APAC Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        APAC Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 16.        APAC Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        APAC Plasma Fractionation Market Share by Application 2021 & 2028 (%)

Figure 18.        APAC Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 19.        APAC Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 20.        APAC Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 21.        APAC Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 22.        APAC Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 23.        APAC Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 24.        APAC Plasma Fractionation Market Share by End User 2021 & 2028 (%)

Figure 25.        APAC Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 26.        APAC Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 27.        APAC Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 28.        APAC Plasma Fractionation Market Overview, by Country (2018)

Figure 29.        APAC: Plasma Fractionation Market, by Country, 2021 & 2028 (%)

Figure 30.        Japan: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31.        China: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 32.        India: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 33.        South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 34.        Australia: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 35.        Rest of APAC: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)

Figure 36.        Impact of COVID-19 Pandemic in APAC Country Markets

Figure 37.        Growth Strategies Followed by Major Market Players (%)

1. Bharat Serums and Vaccines Limited (BSV)
2. Bio Products Laboratory Ltd.
3. CSL Limited
4. Grifols, S.A.
5. Kedrion S.p.A
6. Octapharma AG
7. PlasmaGen BioSciences Pvt. Ltd.
8. SK Plasma

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the APAC plasma fractionation market   
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the APAC plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution